AMNEAL PHARMS NY FDA Approval ANDA 076642

ANDA 076642

AMNEAL PHARMS NY

FDA Drug Application

Application #076642

Documents

Letter2007-10-22
Letter2007-10-22
Letter2007-10-22
Letter2007-10-22
Review2011-01-07

Application Sponsors

ANDA 076642AMNEAL PHARMS NY

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004

Application Products

001TABLET;ORAL7.5MG;200MG0HYDROCODONE BITARTRATE AND IBUPROFENHYDROCODONE BITARTRATE; IBUPROFEN
002TABLET;ORAL5MG;200MG0HYDROCODONE BITARTRATE AND IBUPROFENHYDROCODONE BITARTRATE; IBUPROFEN
003TABLET;ORAL2.5MG;200MG0REPREXAINHYDROCODONE BITARTRATE; IBUPROFEN
004TABLET;ORAL10MG;200MG0REPREXAINHYDROCODONE BITARTRATE; IBUPROFEN

FDA Submissions

ORIG1AP2004-03-18
LABELING; LabelingSUPPL2AP2004-06-16
S; SupplementSUPPL3AP2004-10-12
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2007-10-19
LABELING; LabelingSUPPL6AP2007-10-19
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2007-10-19
LABELING; LabelingSUPPL8AP2007-10-19
LABELING; LabelingSUPPL9AP2007-01-03
LABELING; LabelingSUPPL10AP2007-01-04
MANUF (CMC); Manufacturing (CMC)SUPPL11AP2008-03-20
LABELING; LabelingSUPPL20AP2018-08-15STANDARD
LABELING; LabelingSUPPL22AP2018-08-15STANDARD
LABELING; LabelingSUPPL23AP2018-08-15STANDARD
LABELING; LabelingSUPPL24AP2018-09-21STANDARD
REMS; REMSSUPPL25AP2018-09-18
LABELING; LabelingSUPPL27AP2019-07-22STANDARD
LABELING; LabelingSUPPL28AP2019-10-10STANDARD
LABELING; LabelingSUPPL30AP2021-03-04STANDARD
LABELING; LabelingSUPPL32AP2021-04-28STANDARD

Submissions Property Types

SUPPL3Null0
SUPPL5Null0
SUPPL7Null0
SUPPL11Null0
SUPPL20Null7
SUPPL22Null7
SUPPL23Null7
SUPPL24Null15
SUPPL25Null15
SUPPL27Null15
SUPPL28Null15
SUPPL30Null15
SUPPL32Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
004PrescriptionAB

CDER Filings

AMNEAL PHARMS NY
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 76642
            [companyName] => AMNEAL PHARMS NY
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROCODONE BITARTRATE AND IBUPROFEN","activeIngredients":"HYDROCODONE BITARTRATE; IBUPROFEN","strength":"7.5MG;200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"},{"drugName":"HYDROCODONE BITARTRATE AND IBUPROFEN","activeIngredients":"HYDROCODONE BITARTRATE; IBUPROFEN","strength":"5MG;200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"REPREXAIN","activeIngredients":"HYDROCODONE BITARTRATE; IBUPROFEN","strength":"2.5MG;200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"REPREXAIN","activeIngredients":"HYDROCODONE BITARTRATE; IBUPROFEN","strength":"10MG;200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDROCODONE BITARTRATE AND IBUPROFEN","submission":"HYDROCODONE BITARTRATE; IBUPROFEN","actionType":"7.5MG;200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"HYDROCODONE BITARTRATE AND IBUPROFEN","submission":"HYDROCODONE BITARTRATE; IBUPROFEN","actionType":"5MG;200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"REPREXAIN","submission":"HYDROCODONE BITARTRATE; IBUPROFEN","actionType":"2.5MG;200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"REPREXAIN","submission":"HYDROCODONE BITARTRATE; IBUPROFEN","actionType":"10MG;200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.